Sort
30,917 grants matching “tumor microenvironment”
Project 1: Targeting the PD-1 pathway in HCC
$376,652Ahmed Kaseb · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA
Project 1: Targeting the PD-1 pathway in HCC
$376,651Ahmed Kaseb · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA
Linking Epigenetic-Therapy Induction of Inflammasome Signaling to Generation of a BRCAness Phenotype
$376,634Kenneth P Nephew · Coriell Institute For Medical Research · P50 · FY2021 · CA
Targeting microRNAs in the tumor microenvironment with pHLIP conjugated next generation chemically modified PNAs
$376,615Frank J. Slack · Beth Israel Deaconess Medical Center · R01 · FY2023 · CA
Targeting microRNAs in the tumor microenvironment with pHLIP conjugated next generation chemically modified PNAs
$376,615Frank J. Slack · Beth Israel Deaconess Medical Center · R01 · FY2022 · CA
Actively engaging NK cells during virotherapy to induce neoantigen-specific antitumor immunity
$376,557Xiaoliu Zhang · University Of Houston · R01 · FY2023 · CA
RNase H2 is a novel therapeutic target in triple negative breast cancer
$376,433Shiaw-Yih Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
RNase H2 is a novel therapeutic target in triple negative breast cancer
$376,433Shiaw-Yih Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
The Role of Cancer-Associated Fibroblasts in Thyroid Carcinoma
$376,428Vivian Lee Weiss · Vanderbilt University Medical Center · R01 · FY2024 · CA
Fingerprinting Invasive Membrane Protrusions to Discover Metastatic Signatures
$376,399Richard L. Klemke · University Of California, San Diego · R01 · FY2018 · CA
Fingerprinting Invasive Membrane Protrusions to Discover Metastatic Signatures
$376,399Richard L. Klemke · University Of California, San Diego · R01 · FY2017 · CA
Determination of functional and molecular biomarkers of treatment resistance with multimodal optical spectroscopy
$376,389Narasimhan Rajaram · University Of Arkansas At Fayetteville · R01 · FY2023 · CA
A Multiplex Protein Biomarker-Based Immunoassay for the Early Detection of Bladder Cancer and its Implications in Tumor Biology
$376,346Charles J Rosser · Cedars-Sinai Medical Center · R01 · FY2023 · CA
Steroid hormone regulation of immune responses
$376,338Ana C Anderson · Brigham And Women'S Hospital · R01 · FY2022 · CA
Deconstruct tumor microenvironment in medulloblastoma
$376,260Hui Zong · University Of Virginia · R01 · FY2016 · NS
Project 1 - Molecular Genetics of Human Papillomavirus Infection and Oncogenesis
$376,252Paul F Lambert · University Of Wisconsin-Madison · P01 · FY2019 · CA
The CXCR3 Chemokine System in Cancer Immunotherapy
$376,216Andrew D Luster · Massachusetts General Hospital · R01 · FY2021 · CA
The CXCR3 Chemokine System in Cancer Immunotherapy
$376,216Andrew D Luster · Massachusetts General Hospital · R01 · FY2020 · CA
The Role of IgE in Airway Inflammation
$376,210University Of Chicago · R01 · FY2005 · HL
The Role of IgE in Airway Inflammation
$376,210University Of Chicago · R01 · FY2004 · HL
PROTAC Targeting of Tip60 in Syngeneic Cancer Models Using Cereblon Knock-in Mice
$376,197Wayne William Hancock · Children'S Hosp Of Philadelphia · R01 · FY2024 · CA
In vivo murine models of metastasis for therapeutic testing
$376,196Norman Edward Sharpless · Univ Of North Carolina Chapel Hill · R01 · FY2013 · CA
Core C: Biospecimen, Pathology, and Genomics Core
$376,178David L Rimm · Yale University · P50 · FY2023 · CA
Oncogenic tyrosine kinases inhibitors abrogate DNA repair and sensitive leukemias to PARP inhibitors
$376,152Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2020 · CA
Oncogenic tyrosine kinases inhibitors abrogate DNA repair and sensitive leukemias to PARP inhibitors
$376,152Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2021 · CA